PAR
Click for more information
3.45% 28.0¢ paradigm biopharmaceuticals limited..

Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial, page-25

  1. oxxa23
    5,933 Posts.
    lightbulb Created with Sketch. 1138
    clock Created with Sketch.
    22/02/24
    22:39
    Post #: 72547855
    Sure, but, he likely has the numbers to call an egm and make serious dents should he feel the need to...
    PAR Price at posting: 37.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢ 		Change
-0.010(3.45%) 		Mkt cap ! $97.94M
Open High Low Value Volume
29.0¢ 29.5¢ 28.0¢ $40.10K 140.9K

Buyers (Bids)

No. Vol. Price($)
5 135929 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 20969 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.